← Eichor
Condition: Angiotensin Receptor Neprilysin Inhibitor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Angiotensin Receptor Neprilysin Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF
Phase N/A · 1 location(s) · Future University in Egypt · NCT07347925Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Phase 4 · 4 location(s) · Kyungsub Song · NCT07572032Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06917664Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF
Phase 2 · 1 location(s) · National Medical Research Center for Cardiology, Ministry of · NCT06655480Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
Phase 4 · 1 location(s) · The Cleveland Clinic · NCT04191681
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.